Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,706 | 108 | 78.3% |
| Travel and Lodging | $740.84 | 3 | 21.4% |
| Gift | $10.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $766.14 | 5 | $0 (2024) |
| Spinal Simplicity, LLC | $621.34 | 12 | $0 (2024) |
| Abbott Laboratories | $332.36 | 14 | $0 (2024) |
| Boston Scientific Corporation | $318.98 | 13 | $0 (2024) |
| Medtronic, Inc. | $239.21 | 5 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $177.88 | 11 | $0 (2024) |
| PFIZER INC. | $135.65 | 6 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $85.85 | 2 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $62.95 | 4 | $0 (2019) |
| Depomed, Inc. | $62.74 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,187 | 20 | Genesys Orthopedics Systems, L.L.C. ($766.14) |
| 2023 | $194.00 | 10 | Abbott Laboratories ($53.02) |
| 2022 | $828.11 | 19 | Spinal Simplicity, LLC ($604.66) |
| 2021 | $99.78 | 6 | Abbott Laboratories ($44.44) |
| 2020 | $107.93 | 5 | PFIZER INC. ($74.33) |
| 2019 | $252.02 | 9 | Abbott Laboratories ($153.96) |
| 2018 | $275.56 | 16 | BOSTON SCIENTIFIC CORPORATION ($60.54) |
| 2017 | $512.24 | 27 | Collegium Pharmaceutical, Inc. ($86.93) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neuromodulation | ||||||
| 11/16/2024 | Genesys Orthopedics Systems, L.L.C. | SACROILIAC JOINT FUSION SYSTEM (Device), SACROILIAC JOINT FUSION SYSTEM | Travel and Lodging | Cash or cash equivalent | $396.34 | General |
| Category: Sacroiliac | ||||||
| 11/16/2024 | Genesys Orthopedics Systems, L.L.C. | SACROILIAC JOINT FUSION SYSTEM (Device), SACROILIAC JOINT FUSION SYSTEM | Food and Beverage | Cash or cash equivalent | $216.38 | General |
| Category: Sacroiliac | ||||||
| 11/16/2024 | Genesys Orthopedics Systems, L.L.C. | SACROILIAC JOINT FUSION SYSTEM (Device), SACROILIAC JOINT FUSION SYSTEM | Food and Beverage | Cash or cash equivalent | $105.00 | General |
| Category: Sacroiliac | ||||||
| 11/16/2024 | Genesys Orthopedics Systems, L.L.C. | SACROILIAC JOINT FUSION SYSTEM (Device), SACROILIAC JOINT FUSION SYSTEM | Food and Beverage | Cash or cash equivalent | $38.42 | General |
| Category: Sacroiliac | ||||||
| 11/16/2024 | Genesys Orthopedics Systems, L.L.C. | SACROILIAC JOINT FUSION SYSTEM (Device), SACROILIAC JOINT FUSION SYSTEM | Gift | Cash or cash equivalent | $10.00 | General |
| Category: Sacroiliac | ||||||
| 10/25/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/24/2024 | Boston Scientific Corporation | NA (Device) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: G4 RF Generator_NM | ||||||
| 10/10/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: PAIN | ||||||
| 08/01/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 07/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $135.08 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/25/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: OSTEOARTHRITIS | ||||||
| 04/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/09/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 04/03/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Central Nervous System | ||||||
| 03/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Neuromodulation | ||||||
| 01/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/09/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| 10/17/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Neuromodulation | ||||||
| 10/03/2023 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Orthopedic | ||||||
| 09/27/2023 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $23.66 | General |
| Category: Pain Management | ||||||
| 08/10/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 592 | 2,042 | $570,708 | $156,726 |
| 2022 | 13 | 717 | 1,946 | $429,726 | $138,207 |
| 2021 | 19 | 898 | 1,679 | $468,769 | $140,851 |
| 2020 | 18 | 753 | 1,195 | $560,322 | $94,215 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 87 | 201 | $148,893 | $48,207 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 568 | $125,955 | $37,262 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 340 | $88,400 | $30,189 | 34.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 89 | 203 | $39,372 | $12,255 | 31.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 19 | 22 | $64,500 | $10,819 | 16.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 18 | 24 | $40,250 | $6,473 | 16.1% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 108 | 241 | $31,330 | $5,728 | 18.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 13 | 14 | $11,900 | $2,428 | 20.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 12 | 19 | $11,275 | $1,932 | 17.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 19 | $6,875 | $1,094 | 15.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 16 | 51 | $768.06 | $305.36 | 39.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 25 | 340 | $1,190 | $33.38 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 662 | $119,160 | $42,539 | 35.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 87 | 147 | $108,892 | $35,622 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 275 | $71,500 | $24,892 | 34.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 90 | 153 | $29,674 | $9,243 | 31.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 28 | 35 | $26,691 | $6,639 | 24.9% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 105 | 183 | $23,790 | $4,908 | 20.6% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 18 | 23 | $13,713 | $4,525 | 33.0% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2022 | 39 | 63 | $8,568 | $2,842 | 33.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 23 | 33 | $10,505 | $2,472 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $10,275 | $2,264 | 22.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 38 | 59 | $3,540 | $1,375 | 38.8% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2022 | 13 | 24 | $2,040 | $672.37 | 33.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 15 | 38 | $572.28 | $191.43 | 33.5% |
About Dr. Kamlesh Sisodiya, M.D
Dr. Kamlesh Sisodiya, M.D is a Anesthesiology healthcare provider based in Colleyville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003893397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamlesh Sisodiya, M.D has received a total of $3,457 in payments from pharmaceutical and medical device companies, with $1,187 received in 2024. These payments were reported across 112 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,706).
As a Medicare-enrolled provider, Sisodiya has provided services to 2,960 Medicare beneficiaries, totaling 6,862 services with total Medicare billing of $529,999. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Pain Medicine
- Location Colleyville, TX
- Active Since 12/28/2005
- Last Updated 06/29/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1003893397
Products in Payments
- SACROILIAC JOINT FUSION SYSTEM (Device) $766.14
- HA MINUTEMAN G3-R (Device) $621.34
- INTELLIS ADAPTIVESTIM (Device) $239.21
- Proclaim Family of SCS IPGs (Device) $153.96
- PROCLAIM (Device) $106.39
- WaveWriter Alpha Prime 16 (Device) $93.84
- Spectra WaveWriter (Device) $92.27
- SPECTRA WAVEWRITER (Device) $89.45
- Mobi-C (Device) $85.85
- XTAMPZA (Drug) $76.30
- FLECTOR (Drug) $74.33
- Xtampza ER (Drug) $67.28
- Horizant (Drug) $62.95
- Nucynta (Drug) $62.74
- RELISTOR ORAL (Drug) $61.05
- Victoza (Drug) $48.40
- Evzio (Drug) $45.82
- Proclaim IPG (Device) $44.44
- PENNSAID (Drug) $39.57
- NURTEC ODT (Drug) $37.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.